Gastroenterology : For a functional approach to healing the gut lining
iTRAQ-based quantitative protein expression profiling and MRM verification of markers in type 2 diabetes
However, I would suggest that GLP-1s might be a unique case study, potentially not fully representative of the broader pharmaceutical market
Source: Arrone, et al New England J of Medicine May 11, 2025 Researchers randomized about 1,500 people with obesity and without diabetes to be treated with either tirzepatide or semaglutide, both at the highest tolerable recommended doses, and followed them for 72 weeks
That approach is understandable, but it fragments data across notes, apps, and memory, making it hard to see patterns such as injection timing, hydration dips, or protein gaps